Literature DB >> 12127396

Establishment, characterization, karyotyping, and comparative genomic hybridization analysis of HKESC-2 and HKESC-3: two newly established human esophageal squamous cell carcinoma cell lines.

Ying Chuan Hu1, King Y Lam, Simon Y Law, Thomas S K Wan, Edmond S K Ma, Yok Lam Kwong, Li C Chan, John Wong, Gopesh Srivastava.   

Abstract

The establishment of esophageal cancer cell lines can facilitate the search for molecular mechanisms underlying its pathogenesis. Two novel human esophageal squamous cell carcinoma (ESCC) cell lines, HKESC-2 and HKESC-3, were established from a moderately differentiated ESCC of a 46-year-old Chinese woman and a well-differentiated ESCC of a 74-year-old Chinese man, both from Hong Kong. The pathological characteristics (morphological, immunohistochemical, and electron microscopic studies), tumorigenicity in nude mice, cytogenetic features, and DNA ploidy of the two cell lines were investigated. The two cell lines have been maintained in vitro for more than 17 months and passaged over 85 times for HKESC-2 and 58 times for HKESC-3. Both grew as monolayers, with a doubling time of 24 hours for HKESC-2 and 48 h for HKESC-3. Their squamous epithelial nature was authenticated by their strong immunopositivity with the anti-cytokeratin antibodies and the ultrastructural demonstration of tonofilaments and desmosomes. They are tumorigenic in nude mice and had DNA aneuploidy. G-banding cytogenetic analysis showed hyperdiploidy in HKESC-2 and near-tetraploidy in HKESC-3. Frequent breakpoints were noted at 1p22, 1p32, and 9q34 in HKESC-2 and at 1p31, 3p25, 3p14, 6q16, 6q21, 8p21, 9q34, 13q32, and 17q25 in HKESC-3. Comparative genomic hybridization analysis found that chromosomal gains were at 3q24-qter, 5q21-qter, 8q11-qter, 13q21-q31, 17q11-qter, 19, 22q22 for HKESC-2 and at 3q13-qter, 5p, 6p, 9q21-qter, 10q21-q22, 12q15-pter, 14q24-qter, 16, 17q24-qter, 20 for HKESC-3. Chromosomal losses were at 3p13-pter, 18q12-qter for HKESC-3. These two newly established cell lines will be useful tools in the study of the molecular pathogenesis and biological behavior of ESCC cells and for testing new therapeutic reagents for ESCC in the future.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12127396     DOI: 10.1016/s0165-4608(01)00580-5

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  13 in total

1.  Genomic imbalances in esophageal carcinoma cell lines involve Wnt pathway genes.

Authors:  Jacqueline Brown; Hannelie Bothma; Robin Veale; Pascale Willem
Journal:  World J Gastroenterol       Date:  2011-06-28       Impact factor: 5.742

2.  Authentication of newly established human esophageal squamous cell carcinoma cell line (YM-1) using short tandem repeat (STR) profiling method.

Authors:  Khosravi Ayyoob; Khoshnia Masoud; Kazeminejad Vahideh; Asadi Jahanbakhsh
Journal:  Tumour Biol       Date:  2015-10-02

3.  Prognostic significance of phosphorylated RON in esophageal squamous cell carcinoma.

Authors:  Marco K C Hui; Kenneth K Y Lai; Kwok Wah Chan; John M Luk; Nikki P Lee; Yvonne Chung; Leo C Cheung; Gopesh Srivastava; Sai Wah Tsao; Johnny C Tang; Simon Law
Journal:  Med Oncol       Date:  2011-11-16       Impact factor: 3.064

4.  Macrophage migration inhibitory factor stimulates angiogenic factor expression and correlates with differentiation and lymph node status in patients with esophageal squamous cell carcinoma.

Authors:  Yi Ren; Simon Law; Xin Huang; Ping Yin Lee; Michael Bacher; Gopesh Srivastava; John Wong
Journal:  Ann Surg       Date:  2005-07       Impact factor: 12.969

5.  Aberrant methylation of the PTPRO gene in peripheral blood as a potential biomarker in esophageal squamous cell carcinoma patients.

Authors:  Yan-Jie You; Yu-Ping Chen; Xiao-Xuan Zheng; Stephen J Meltzer; Hao Zhang
Journal:  Cancer Lett       Date:  2011-09-12       Impact factor: 8.679

6.  Novel esophageal squamous cell carcinoma bone metastatic clone isolated by scintigraphy, X ray and micro PET/CT.

Authors:  Bi-Zeng Zhao; Jie Cao; Jin-Chen Shao; Yan-Bing Sun; Li-Min Fan; Chun-Yu Wu; Sheng Liang; Bao-Feng Guo; Guang Yang; Wen-Hui Xie; Qing-Cheng Yang; Shun-Fang Yang
Journal:  World J Gastroenterol       Date:  2014-01-28       Impact factor: 5.742

7.  The pathogenesis of Barrett's esophagus: secondary bile acids upregulate intestinal differentiation factor CDX2 expression in esophageal cells.

Authors:  Yingchuan Hu; Valerie A Williams; Oliver Gellersen; Carolyn Jones; Thomas J Watson; Jeffrey H Peters
Journal:  J Gastrointest Surg       Date:  2007-07       Impact factor: 3.452

8.  Clinical correlation of nuclear survivin in esophageal squamous cell carcinoma.

Authors:  Marco K C Hui; Kenneth K Y Lai; Kwok Wah Chan; John M Luk; Nikki P Lee; Yvonne Chung; Leo C M Cheung; Gopesh Srivastava; Sai Wah Tsao; Johnny C Tang; Simon Law
Journal:  Med Oncol       Date:  2012-04-19       Impact factor: 3.064

9.  Cytoplasmic Forkhead box M1 (FoxM1) in esophageal squamous cell carcinoma significantly correlates with pathological disease stage.

Authors:  Marco K C Hui; Kwok Wah Chan; John M Luk; Nikki P Lee; Yvonne Chung; Leo C M Cheung; Gopesh Srivastava; Sai Wah Tsao; Johnny C Tang; Simon Law
Journal:  World J Surg       Date:  2012-01       Impact factor: 3.352

10.  Genetic profiling reveals cross-contamination and misidentification of 6 adenoid cystic carcinoma cell lines: ACC2, ACC3, ACCM, ACCNS, ACCS and CAC2.

Authors:  Janyaporn Phuchareon; Yoshihito Ohta; Jonathan M Woo; David W Eisele; Osamu Tetsu
Journal:  PLoS One       Date:  2009-06-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.